Escape the Diet Traps Stop starving yourself
Future research should aim to unravel the precise molecular mechanisms underlying these weight-independent benefits, enabling the development of new therapies that harness these anti-inflammatory pathways and potentially bypass the limitations of current interventions
A dual GIP and GLP-1 receptor agonist, supplied as a 10mg lyophilised vial
We evaluate pivotal clinical trial data, including SURPASS, SURMOUNT, and STEP program results, highlighting differences in average weight loss, metabolic effects, and tolerability
Barbagelata L, Masson W, Lobo M, et al